Table 1 Clinical, laboratory and demographic features of 32 patients with cirrhosis treated with transjugular intrahepatic portosystemic shunt.
| Variable | |
|---|---|
| Age (years) | 61 (1.6) |
| Sex (M/F) | 21/11 |
| Aetiology (viral/alcohol/other) | 14/11/7 |
| TIPS indication (bleed/ascites) | 10/22 |
| Child–Pugh class (A/B/C) | 4/19/9 |
| Child–Pugh score | 8 (0.3) |
| MELD score | 10 (0.8) |
| Serum bilirubin (μmol/l) | 35.9 (3.4) |
| Serum albumin (g/l) | 30 (1.2) |
| INR (ratio) | 1.23 (0.02) |
| ALT (U/l) | 33 (3) |
| Serum creatinine (μmol/l) | 90.1 (6.2) |
| Serum sodium (mmol/l) | 135 (1) |
| Ascites (absent/mild/severe) | 5/7/20 |
ALT, alanine aminotransferase; F, female; INR, international normalised ratio; M, male; MELD, model of end‐stage liver disease; TIPS, transjugular intrahepatic portosystemic shunt.
Values are mean (SD) unless they are otherwise defined.